VC Fund Investments
Oncology-focused Biotech startup Exsure raises Rs.3-Cr led by Unicorn India Ventures
Bhubaneswar-based biotech startup Exsure has raised INR 3 crore in a seed funding round led by Unicorn India Ventures. The fresh funds will be used to complete the non-clinical study of its exosome-based drug delivery platform, support its global expansion plans with its R&D products, and promote its offerings, including Exosure, Leucosure, PlantExosure, and Dr. Berries.Founded in 2021 by Swastika Paul and Abhishek Dutta, Exsure is focused on reducing the side effects and toxicity of anti-cancer drugs through its patented exosomal drug-delivery platform that targets both cancer and cancer stem cells. The company aims to minimize the toxic effects of chemotherapy and reduce the likelihood of cancer relapse.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
